Pharmacodynamics (PD) and Pharmacokinetics (PK) Study of EP-100 in Advanced Solid Tumors
Clinical trial NCT00949559 · COMPLETED
Trial details
- NCT number
- NCT00949559
- Sponsor
- Esperance Pharmaceuticals Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-07-01
- Primary completion
- 2012-03-01
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.